Methods: This multicenter cohort study included 2373 patients with acute ischemic stroke treated with intravenous thrombolysis between December 2004 and December 2016. Of these, 1845 patients were categorized into either the hyperlipidemia or non-hyperlipidemia group. Symptomatic ICH (SICH) rates within 24 -36 h of thrombolytic onset and functional outcomes at 30 and 90 days were longitudinally surveyed. Models of predicting hemorrhagic transformation were used to validate our findings. Conclusions: This study supports the strong association between reduced LDL-C and increased SICH, but not for functional outcomes in patients with acute ischemic stroke treated with intravenous thrombolysis. LDL-C level of 130 mg/dL is supposed to a candidate marker for predicting SICH within 24 -36 h. surement of total cholesterol, LDL-C, HDL-C, and triglycerides (TG) in a fasting state (measured during 24 -72 h following IV alteplase administration). Exclusion criteria for IV thrombolysis referred to the SITS-MOST study standard 16) . All enrolled patients with acute ischemic stroke underwent brain computed tomography (CT) on arrival at the emergency department, and another routine repeat brain CT was conducted within 24 -36 h post IV thrombolysis. Baseline demographic data including age, sex, weight, history of hypertension, diabetes mellitus, hyperlipidemia, coronary artery disease, atrial fibrillation, alcohol consumption, blood pressure on arrival, use of antiplatelet and anticoagulant medications, baseline National Institutes of Health Stroke Scale (NIHSS) score, the alteplase dose, and time from stroke onset to IV thrombolysis were retrieved by investigators. Patients with a capacity of will signed the informed consent themselves, whereas it was signed by legal surrogate in case of patients without a capacity of will. This study was approved by the institutional review board of Kaohsiung Medical University Hospital.
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Outcomes Measures
Regarding primary and secondary objectives, we evaluated the relationship between SICH and lipid profiles in two ways: (1) groups of hyperlipidemia and non-hyperlipidemia (the hyperlipidemia group was defined as total cholesterol of ≥ 200 mg/dL or LDL-C of ≥ 130 mg/dL or TG of ≥ 200 mg/dL) and (2) total cholesterol, LDL-C, HDL-C, and TG as continuous variables (mg/dL). Patients were longitudinally surveyed at 30 and 90 days for functional outcome measurement. The modified Rankin Scale (mRS) of 0 -1 or 0 -2 was defined as favorable functional outcomes 17) . SICH was defined by three criteria: (1) the National Institute of Neurological Disorders (NINDS) study standard in which any intracranial hemorrhage with deterioration of NIHSS scores of ≥ 1 or death within 36 h 15) , (2) the European Cooperative Acute Stroke Study (ECASS) II standards in which any apparently extravascular blood in the cranium with deterioration of NIHSS scores of ≥ 4 or led to death 18) , and (3) the SITS-MOST standards in which a type 2 parenchymal hemorrhage (a local or remote parenchymal intracranial hemorrhage exceeding 30% of the infarct) with clinical deterioration of NIHSS scores of ≥ 4 or death within 36 h 16) .
Introduction
The level of non-high-density lipoproteins (non-HDL-C) was recognized as a possible modifying factor of intracranial hemorrhage in the multinational INTERSTROKE case -control study 1) . Later, several studies found decreased total or low-density cholesterol (LDL-C) as the candidate risk factor for spontaneous intracranial hemorrhage [2] [3] [4] . A 2007 study with a small sample of 104 patients provided the first evidence supporting the association between cholesterol levels and hemorrhagic transformation after intravenous (IV) thrombolysis for acute ischemic stroke 5) . Nevertheless, later studies on similar topics reported inconsistent results [5] [6] [7] [8] [9] [10] . These studies were possibly limited by their smaller sample sizes (enrolling fewer than 500 patients) [5] [6] [7] 10) , retrospective design [5] [6] [7] [8] 10) , and missing lipid profiles in a substantial portion of patients 9) . By contrast, none of the studies determined as to how much a lower level of cholesterol contributed to the increase in symptomatic intracranial hemorrhage (SICH) 5) or conducted a longitudinal research on changes in the functional status in these patients. Thus, the association between decreased cholesterol levels and increased hemorrhagic transformation for acute ischemic stroke treated with IV thrombolysis is yet to be elucidated 7, 11, 12) . The Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) registry is a nationwide cohort in Taiwan and contains longitudinal follow-up data with each patient's clinical and laboratory characteristics for 90 days 13, 14) . We sought to determine whether lipid profiles (1) modified the incidence of hemorrhagic transformation at 24 -36 h, and (2) altered the functional status changes in patients with acute ischemic stroke patients treated with IV thrombolysis among ethnic Chinese (i.e., Taiwanese).
Methods

Design and Participants
This multicenter cohort study included 30 hospitals in Taiwan, and the data were prospectively collected and registered in the TTT-AIS registry system. For patients with acute ischemic stroke, IV alteplase was adopted as the thrombolytic regimen at arrival within 3 h of stroke onset. Eligible patients fulfilled the inclusion criteria of (1) treatment with IV thrombolysis adhering to the National Institute for Neurological Disorders (NINDS) standard 15) and (2) mea-
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one). These risk-scoring systems contained the Hemorrhage After Thrombolysis (HAT) score 19) , the Safe Implementation of Thrombolysis in Stroke (SITS-SICH) score 20) , the Cucchiara score 21) , the blood Sugar, Early infarct signs and hyperDense cerebral artery sign, Age, and NIHSS (SEDAN) score 22) , the Stroke Prognostication using Age and National Institutes of Health Stroke Scaleand-100 (SPAN-100) index 23) , the Glucose Race Age Sex Pressure Stroke Severity (GRASPS) score 24) , and the Totaled Health Risks in Vascular Events (THRIVE) score 25) (Supplemental Table 1 ). As a separate part of the study, we investigated the subcohort of possibly statin-naive patients. Because the
Validation Study
As a separate part of the study, we verified which lipid profile was a candidate marker for predicting SICH. In the current systems, there were seven validated risk-scoring models available for us to predict hemorrhagic transformation for acute ischemic stroke treated with IV thrombolysis. The candidate lipid profile was then incorporated into to the original riskscoring models, which in succession became the new model. We certified a lipid profile that was in actual association with SICH by contrasting the original and new risk-scoring models (when new models had significantly better diagnostic ability than the original 90 days. The multivariate regressions were applied to adjust the significantly imbalanced covariates between the hyperlipidemia and non-hyperlipidemia groups. However, covariates of the antithrombotic medications were not adjusted because of missing values in most subjects. In the validation study, receiver of operating characteristics (ROC) curves were conducted to examine the diagnostic ability of each model. The Hosmer -Lemeshow test was used to examine the model of fitness (good fitness of the model was defined as p 0.05). The integrated discriminatory improvement (IDI) test was used to compare the predictive ability between the original and new models 26, 27) . Statistical significance was set at a p value of 0.05. All analyses were performed using SAS 9.4 software (SAS Institute, Cary, NC, USA).
Taiwan National Health Insurance (TNHI) system had strict payment rule for statin, the subcohort was defined as exclusion of the TNHI rule (LDL-C of ≥ 130 mg/dL or total cholesterol of ≥ 200 mg/dL with diabetes mellitus or more than one of the following cardiovascular risk factors: HDL of 40 mg/dL, hypertension, male patient aged ≥ 40 years, female menopausal patient aged ≥55 years, or smoking). These results are shown in Supplemental Fig. 3 and Table 4 .
Statistical Analysis
To compare the two groups, Student t -test was used for continuous variables and Chi-squared test was used for categorical variables. For outcomes measures, Poisson regression model was used to determine the relative risk (RR) of SICH in the 24 -36 h of interval and Binomial regression model was used to evaluate the RR for the functional outcomes at 30 and (Fig. 2) .
Secondary Objective (Each Lipid Profile)
The association between SICH and each lipid profile is shown in Table 3 . Increasing total cholesterol and TG levels decreased the risk of developing SICH, but they showed solitary significance in the ECASS II standard (adjusted RR, 0.908 per 10 mg/ dL; 95% CI, 0.830 -0.992; p 0.0331) and the SITS-MOST (adjusted RR, 0.837 per 10 mg/dL; 95% CI, 0.722 -0.970; p 0.0331), respectively. By contrast, only LDL-C showed a significant association with all SICH standards -the NINDS standard (adjusted RR, 0.912 per 10 mg/dL; 95% CI, 0.848 -0.982; p 0.0145), the ECASS II standard (adjusted RR, 0.823 per 10 mg/dL; 95% CI, 0.742 -0.913; p 0.0002), and the SITS-MOST standard (adjusted RR, 0.846 per 10 mg/ dL; 95% CI, 0.724 -0.989; p 0.0358). The increased HDL-C level manifested an increased risk of SICH, but it was exclusively significant for the ECASS II standard (adjusted RR, 0.837 per 10 mg/dL; 95% CI, 0.722 -0.970; p 0.0182).
Results
Baseline Demographic Characteristics
A total of 2373 patients with acute ischemic stroke who completed the IV thrombolysis treatment between December 1, 2004 and December 31, 2016 were registered in TTT-AIS I and II systems ( Fig. 1) . Complete lipid profile data in a fasting state were measured in 1845 patients following admission ( Table  1) . The hyperlipidemia cohort included 747 patients, and the non-hyperlipidemia cohort included 1093 patients. The non-hyperlipidemia group was more likely to include older patients, those with a comorbidity of atrial fibrillation, those using aspirin, those with higher baseline NIHSS scores, and those using low-dose alteplase. The hyperlipidemia group consisted of more patients with higher systolic and diastolic blood pressure at arrival. There were no significant differences in the sex distribution; comorbidities of hypertension, diabetes mellitus, coronary artery disease, and alcoholism; or time from stroke onset to IV thrombolysis between the two groups.
Primary Objective (Hyperlipidemia vs Non-Hyperlipidemia Group)
The rates of any intracranial hemorrhage (ICH) were 12.3% and 15.6% for hyperlipidemia and nonhyperlipidemia groups, respectively ( Fig. 1) . Rates of SICH for hyperlipidemia and non-hyperlipidemia groups according to the NINDS, ECASS II, and SITS-MOST standards are shown in Table 2 . The hyperlipidemia group had a significantly reduced incidence rate of SICH than the non-hyperlipidemia group by the NINDS standard (2.28% vs 4.85%; adjusted RR, 0.509; 95% CI, 0.277 -0.933; p 0.0290), the ECASS thrombolysis, but not for the favorable functional outcomes at 30 and 90 days. The study confirmed that the association between the lipid profile and SICH was mostly attributable to LDL-C, and a level of LDL-C 130 mg/dL had the greatest significant association with increased SICH.
In our cohorts, the ICH and SICH rates varied according to the NINDS, ECASS II, and SITS-MOST. Because the SITS-MOST standard had the most conservative definition, the SICH rates were markedly reduced in the hyperlipidemia and non-hyperlipidemia groups (0.27% and 1.46%, respectively). This was comparable to previous literature 13, 14) and also reflected realworld data among Asian population. Moreover, our cohorts had high follow-up rates in both groups (92.2% and 90.4%, respectively, at 30 days; 86.1% and 87.7%, respectively, at 90 days). These high follow-up rates should strengthen our research by avoiding the selection bias.
In the validation section, we confirmed LDL-C had high diagnostic ability in predicting hemorrhagic transformation. Each of the modified risk scoring model implementing LDL-C variable had higher ROC statistics (the area under curve) in predicting SICH and maintained stable goodness of fit. The modified models in a way of LDL-C discrete points also exempted
Validation Study
LDL-C, which exhibited the most robust association with SICH in our study, was incorporated into all of our available and validated hemorrhagic transformation predicting models in two ways: continuous level and discrete points. To obtain a higher sensitivity, we determined a cut-off of LDL-C of 100 -130 mg/ dL as a point of 1, and LDL-C 100 mg/dL as a point of 2. For the new models with LDL-C as continuous levels, all the models showed significantly exceeding improvement in diagnostic ability. The ROC contrast results were all significant as well (Supplemental Table  2 ). In addition, the diagnostic ability of all models improved on adding the LDL-C discrete points, and most of them were effective in model stability and fitness (Supplemental Table 3 ). By applying the new models, our patients had better predictability of SICH in the NINDS standard (Fig. 3) , the ECASS II standard (Supplemental Fig. 1) , and STIS-MOST standard (Supplemental Fig. 2 ).
Discussion
In this investigation, hyperlipidemia had a robust protective effect on the development of SICH among patients with acute ischemic stroke treated with IV The distinctive strengths of our study are (1) a longitudinal cohort study design with a large sample size of patients treated with a thrombolytic agent in comparison to previous studies, (2) determination of how much a lower level of LDL-C contributed to increase hemorrhagic transformation of SICH, (3) a solid definition of SICH by the NINDS, ECASS II, and SITS-MOST standards, (4) a validation study to substantiate our findings, and (5) a proper statistical estimation. We adopted the Poisson regression instead of logistic regression model because the former produces a more unbiased estimate when adjusting for confounders 36, 37) and our prime data fulfilled the assumption of the Poisson regression (the count of SICH events was rare and the sample size of enrolled patients was large).
This study has some limitations. First, the TTT-AIS registry 13, 14) has no exact information on whether patients treated with a thrombolytic agent took statins. However, we may identify the patients who were possibly statin-naive because the TNHI system had strict payment rule for statin and covered all residents in Taiwan. Although we cannot thoroughly discuss the interaction with statins, we found that these possibly statin-naive patients still had an increased association between low LDL-C and SICH (Supplemental Fig. 3 and Supplemental Table 4 ). Second, the TTT-AIS registry 13, 14) had not enrolled patients treated with intra-arterial thrombectomy. The TTT-AIS was launched in 2004 at that time the intra-arterial thrombectomy from the doubt of increasing diagnostic ability by adding another variable. For an example, the discrete points models of HAT score synthesized all scoring variables (including the LDL-C) into single value in a range from 0, 1, 2, ≥ 3 which called as total score. Only the total score was used as the independent variable in these modified models. These modified models verified our judgment and raised the practical ability (Fig. 3,  Supplemental Figs. 1 and 2) .
From earlier studies such as the INTERSTROKE study, we recognized that non-HDL-C was possibly connected with spontaneous ICH occurrence. Our study showed that increased TG may be protective, but it was only significant in the SITS-MOST standard. Referred to the previous literature of TG, which showed inconsistent results [28] [29] [30] [31] [32] , we supposed TG was not a reliable marker for hemorrhagic transformation. For increased HDL-C level, our results showed a paradoxically raised risk of hemorrhagic transformation despite only significant in the ECASS II standard. The relevant studies showed a similar trend for HDL-C 29, 30, 33, 34) , but most of their results were not significant like our study results. Regarding LDL-C, a recent study proposed that admission ICH volume in cube root was inversely proportional to admission LDL-C levels 35) . We considered that low LDL-C may modify the SICH through increasing ICH volume expansion, but all lipid profiles did not effectively alter the long-term outcomes. This warrants further studies. tation of data. S.F.L wrote the first draft of the article.
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In conclusion, this study supports an association between reduced lipid profiles and increased SICH among patients with acute ischemic stroke treated with IV thrombolysis. LDL-C level of 130 mg/dL is a candidate marker indicating increased SICH after IV thrombolysis.
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